PYC pyc therapeutics limited

With respect to the Soucek et al abstract to be presented on 20...

  1. 6,308 Posts.
    lightbulb Created with Sketch. 22450
    With respect to the Soucek et al abstract to be presented on 20 April at the American Council of Cancer Research’s Annual Meeting , from the abstract body

    Here we discuss our current research with Omomyc and our efforts to develop a clinically viable approach to Myc inhibition.

    One is based on the direct use of Omomyc itself as a peptide since we have discovered that it natively possesses cell-penetrating activity and it rapidly biodistributes to the lung and brain after intranasal administration.

    What does “natively possesses” mean in this context?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.29
Change
0.015(1.18%)
Mkt cap ! $749.4M
Open High Low Value Volume
$1.27 $1.29 $1.27 $13.77K 10.73K

Buyers (Bids)

No. Vol. Price($)
1 7873 $1.27
 

Sellers (Offers)

Price($) Vol. No.
$1.29 715 2
View Market Depth
Last trade - 10.36am 30/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.